Site-Specific Immunomodulator: A Novel Treatment for Crohn’s Disease
Brian Bressler(University of British Columbia), Hal Gunn, Kevin P. Bethel(Antiquities, Monuments and Museum Corporation), Ralf Kleef, David W. Mullins(Wake Forest University), Sophie Reynolds, Simon Sutcliffe
Cited by 11
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478